These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36638354)

  • 61. A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer.
    Iyer RV; Pokuri VK; Groman A; Ma WW; Malhotra U; Iancu DM; Grande C; Saab TB
    Am J Clin Oncol; 2018 Jul; 41(7):649-655. PubMed ID: 27849649
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan.
    Nagakawa T; Kayahara M; Ikeda S; Futakawa S; Kakita A; Kawarada H; Matsuno M; Takada T; Takasaki K; Tanimura H; Tashiro S; Yamaoka Y
    J Hepatobiliary Pancreat Surg; 2002; 9(5):569-75. PubMed ID: 12541042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Biliary tract carcinomas. II. Biliary tract cancer].
    Merdzhanov A; Damianov D; Aleksandrova A; Evtimov G
    Vutr Boles; 1981; 20(5):39-45. PubMed ID: 6275611
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A retrospective study of chemotherapy with cisplatin plus gemcitabine after the failure of gemcitabine monotherapy for biliary tract cancer.
    Kameda R; Ando T; Kobayashi S; Ueno M; Ohkawa S
    Jpn J Clin Oncol; 2013 Jun; 43(6):636-40. PubMed ID: 23619988
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy.
    Choi IS; Kim KH; Lee JH; Suh KJ; Kim JW; Park JH; Kim YJ; Kim JS; Kim JH; Kim JW
    Eur J Cancer; 2021 Sep; 154():288-295. PubMed ID: 34303267
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Cases of biliary neoplasms treated by surgery].
    STEFANOWSKI M; BLICHOWSKI A
    Pol Tyg Lek (Wars); 1956 May; 11(19):835-9. PubMed ID: 13349747
    [No Abstract]   [Full Text] [Related]  

  • 67. Status of surgical treatment of biliary tract cancer.
    Ishihara S; Miyakawa S; Takada T; Takasaki K; Nimura Y; Tanaka M; Miyazaki M; Nagakawa T; Kayahara M; Horiguchi A
    Dig Surg; 2007; 24(2):131-6. PubMed ID: 17446708
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders.
    Su WC; Shiesh SC; Liu HS; Chen CY; Chow NH; Lin XZ
    Dig Dis Sci; 2001 Jul; 46(7):1387-92. PubMed ID: 11478488
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A survey on the diagnosis and treatment of biliary tract cancers in Shanghai].
    Wang BS; Qin J; Deng J; Zhang BH; Han TQ; Shen MC; Rashid A; Hsing AW; Gao YT
    Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):455-9. PubMed ID: 15854373
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bilioenterostomy enhances biliary carcinogenesis in hamsters.
    Ikematsu Y; Tomioka T; Yamanaka S; Tajima Y; Tsunoda T; Kanematsu T
    Carcinogenesis; 1996 Jul; 17(7):1505-9. PubMed ID: 8706256
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical characteristics of pancreatic and biliary tract cancers associated with Lynch syndrome.
    Takamizawa S; Morizane C; Tanabe N; Maruki Y; Kondo S; Hijioka S; Ueno H; Sugano K; Hiraoka N; Okusaka T
    J Hepatobiliary Pancreat Sci; 2022 Mar; 29(3):377-384. PubMed ID: 34689428
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study.
    Valle JW; Vogel A; Denlinger CS; He AR; Bai LY; Orlova R; Van Cutsem E; Adeva J; Chen LT; Obermannova R; Ettrich TJ; Chen JS; Wasan H; Girvan AC; Zhang W; Liu J; Tang C; Ebert PJ; Aggarwal A; McNeely SC; Moser BA; Oliveira JM; Carlesi R; Walgren RA; Oh DY
    Lancet Oncol; 2021 Oct; 22(10):1468-1482. PubMed ID: 34592180
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis.
    Belkouz A; Labeur TA; Dierks J; Dijk F; van Oijen MGH; Verheij J; van Gulik TM; van de Vijver MJ; Wilmink H; Punt CJA; Klümpen HJ
    Crit Rev Oncol Hematol; 2019 Sep; 141():82-94. PubMed ID: 31255992
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Indications for neoadjuvant, adjuvant, and palliative chemotherapy in the treatment of biliary tract cancers.
    Huitzil-Melendez FD; O'Reilly EM; Duffy A; Abou-Alfa GK
    Surg Oncol Clin N Am; 2009 Apr; 18(2):361-79, x. PubMed ID: 19306817
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
    Filippi R; Montagnani F; Lombardi P; Fornaro L; Aprile G; Casadei-Gardini A; Faloppi L; Palloni A; Satolli MA; Scartozzi M; Citarella F; Lutrino SE; Vivaldi C; Silvestris N; Rovesti G; Rimini M; Aglietta M; Brandi G; Leone F
    Acta Oncol; 2021 Oct; 60(10):1317-1324. PubMed ID: 34282710
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Geographical distribution of biliary tract cancer in Niigata prefecture.
    Kato K; Akai S
    Jpn J Clin Oncol; 1990 Mar; 20(1):67-71. PubMed ID: 2319700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Surgical treatment of cancer of the biliary tract and gall bladder].
    Nakayama T; Shimada S; Kinoshita H; Kosuga K
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1264-8. PubMed ID: 2069396
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Granular cell tumor of the biliary tract and bile ducts].
    Dusoleil A; Lahoud S; Condat B; Bellanger J; Fritsch J; Berthelot P; Bedossa P; Pelletier G; Buffet C
    Gastroenterol Clin Biol; 1999; 23(8-9):993-4. PubMed ID: 10533155
    [No Abstract]   [Full Text] [Related]  

  • 79. Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study.
    Larsen FO; Markussen A; Diness LV; Nielsen D
    Oncology; 2018; 94(1):19-24. PubMed ID: 28930749
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combined chemotherapy of irinotecan and low-dose cisplatin (I/low-P) against metastatic biliary tract cancer.
    Sugita H; Hirota M; Ichihara A; Furuhashi S; Kihara S; Shimada S
    J Hepatobiliary Pancreat Surg; 2006; 13(5):463-7. PubMed ID: 17013724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.